1. Variants in MEF2A gene in relation with coronary artery disease in Saudi population
   Seema Zargar et al, 2018, 3 Biotech CrossRef
2. Myocyte enhancer factor 2A delays vascular endothelial cell senescence by activating the PI3K/p-Akt/SIRT1 pathway
   Benrong Liu et al, 2019, Aging CrossRef
3. MEF2A alters the proliferation, inflammation-related gene expression profiles and its silencing induces cellular senescence in human coronary endothelial cells
   Yujuan Xiong et al, 2019, BMC Molecular Biology CrossRef
4. Myocyte Enhancer Factor 2A Plays a Central Role in the Regulatory Networks of Cellular Physiopathology
   Benrong Liu et al, 2022, Aging and disease CrossRef
5. A Novel Gene CDC27 Causes SLE and Is Associated With the Disease Activity
   Shunlai Shang et al, 2022, Frontiers in Immunology CrossRef
6. Identification and genomic analysis of pedigrees with exceptional longevity identifies candidate rare variants
   Justin B. Miller et al, 2020, Neurobiology of Disease CrossRef
7. Contribution of genetic variants in the development of familial premature coronary artery disease in a cohort of cardiac patients
   Sepideh Mehvari et al, 2024, Clinical Genetics CrossRef
8. A Genomic Approach to Characterize the Vulnerable Patient – a Clinical Update
   Evelin Szabó et al, 2019, Journal of Interdisciplinary Medicine CrossRef
9. The Genetics of Coronary Heart Disease
   Jeanette Erdmann et al, 2019, Genetic Causes of Cardiac Disease CrossRef